aTYR PHARMA INC 10-K filing
Filed 2026-03-05 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001339970-26-000008
- Form type
- 10-K
- CIK
- 0001339970
- Primary document
- https://www.sec.gov/Archives/edgar/data/1339970/000133997026000008/atyr-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for aTYR PHARMA INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $190,000 | - | - |
| Operating Income | $-77.6M | - | - |
| Net Income | $-74.1M | - | - |
| Eps Basic | -0.8 | - | - |
| Eps Diluted | -0.8 | - | - |
| Cash And Equivalents | $10.7M | - | - |
| Total Assets | $93.0M | - | - |
| Shareholders Equity | $67.5M | - | - |
| Operating Cash Flow | $-62.0M | - | - |
| Capital Expenditures | $77,000 | - | - |